Literature DB >> 22972864

Acute otitis media replacement and recurrence in the Finnish otitis media vaccine trial.

Jukka Jokinen1, Arto A Palmu, Terhi Kilpi.   

Abstract

We reanalyzed the 7-valent pneumococcal conjugate vaccine trial FinOM for prevention of acute otitis media (AOM), with a focus on disease replacement due to other pathogens and AOM recurrence. We found evidence of replacement disease occurring early during the trial follow-up and little vaccine impact on recurrent overall AOM episodes.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22972864     DOI： 10.1093/cid/cis799

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan.

Authors:  Chun-Yi Lu; Ching-Hu Chung; Li-Min Huang; Eliza Kruger; Seng-Chuen Tan; Xu-Hao Zhang; Nan-Chang Chiu
Journal:  Cost Eff Resour Alloc       Date:  2020-08-28

2.  Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media.

Authors:  Isabelle Hau; Corinne Levy; Laurence Caeymaex; Robert Cohen
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

3.  Nasopharyngeal bacterial carriage in young children in Greenland: a population at high risk of respiratory infections.

Authors:  J E Navne; M L Børresen; H C Slotved; M Andersson; M Melbye; K Ladefoged; A Koch
Journal:  Epidemiol Infect       Date:  2016-07-13       Impact factor: 4.434

4.  Pneumococcal conjugate vaccines for preventing acute otitis media in children.

Authors:  Alexandre C Fortanier; Roderick P Venekamp; Chantal Wb Boonacker; Eelko Hak; Anne Gm Schilder; Elisabeth Am Sanders; Roger Amj Damoiseaux
Journal:  Cochrane Database Syst Rev       Date:  2019-05-28

5.  Pneumococcal conjugate vaccines for preventing acute otitis media in children.

Authors:  Joline Lh de Sévaux; Roderick P Venekamp; Vittoria Lutje; Eelko Hak; Anne Gm Schilder; Elisabeth Am Sanders; Roger Amj Damoiseaux
Journal:  Cochrane Database Syst Rev       Date:  2020-11-24

6.  Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.

Authors:  Emmanuelle Delgleize; Oscar Leeuwenkamp; Eleni Theodorou; Nicolas Van de Velde
Journal:  BMJ Open       Date:  2016-11-30       Impact factor: 2.692

7.  Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.

Authors:  Xavier Sáez-Llorens; Stella Rowley; Digna Wong; Mirna Rodríguez; Arlene Calvo; Marisol Troitiño; Albino Salas; Vielka Vega; Maria Mercedes Castrejón; Patricia Lommel; Thierry G Pascal; William P Hausdorff; Dorota Borys; Javier Ruiz-Guiñazú; Eduardo Ortega-Barría; Juan Pablo Yarzabal; Lode Schuerman
Journal:  Hum Vaccin Immunother       Date:  2017-02-25       Impact factor: 3.452

8.  Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children.

Authors:  Johan Emdal Navne; Anders Koch; Hans-Christian Slotved; Mikael Andersson; Mads Melbye; Karin Ladefoged; Malene Børresen
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

9.  Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.

Authors:  Miguel W Tregnaghi; Xavier Sáez-Llorens; Pio López; Hector Abate; Enrique Smith; Adriana Pósleman; Arlene Calvo; Digna Wong; Carlos Cortes-Barbosa; Ana Ceballos; Marcelo Tregnaghi; Alexandra Sierra; Mirna Rodriguez; Marisol Troitiño; Carlos Carabajal; Andrea Falaschi; Ana Leandro; Maria Mercedes Castrejón; Alejandro Lepetic; Patricia Lommel; William P Hausdorff; Dorota Borys; Javier Ruiz Guiñazú; Eduardo Ortega-Barría; Juan P Yarzábal; Lode Schuerman
Journal:  PLoS Med       Date:  2014-06-03       Impact factor: 11.069

10.  Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea.

Authors:  Xu-Hao Zhang; Oscar Leeuwenkamp; Kyu-Bin Oh; Young Eun Lee; Chul-Min Kim
Journal:  Hum Vaccin Immunother       Date:  2017-11-08       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.